Marina Marchetti Selected Research

Marina Marchetti Research Topics

Disease

24	Neoplasms (Cancer) 01/2023 - 08/2003
15	Thrombosis (Thrombus) 10/2023 - 01/2003
10	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2008
9	Essential Thrombocythemia 01/2014 - 05/2007
6	Hemorrhage 08/2022 - 01/2003
6	Polycythemia Vera 07/2013 - 11/2008
4	Inflammation (Inflammations) 01/2022 - 02/2006
3	Venous Thromboembolism 09/2023 - 05/2010
3	Thrombophilia 01/2022 - 10/2007
3	COVID-19 01/2022 - 01/2021
2	Thrombotic Thrombocytopenic Purpura 10/2023 - 01/2020
2	Lung Neoplasms (Lung Cancer) 09/2023 - 02/2011
2	Thrombasthenia (Glanzmann Thrombasthenia) 01/2022 - 12/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2021
2	Leukemia 11/2012 - 02/2011
2	Activated Protein C Resistance (APC Resistance) 01/2012 - 11/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Disease Progression 09/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2022
1	Ischemia 08/2022
1	Hematoma 08/2022
1	Ischemic Colitis 08/2022
1	Pulmonary Embolism 08/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Hemophilia A (Haemophilia) 12/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Lymphatic Metastasis 01/2020
1	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells 12/2019
1	Shock 01/2018
1	Familial Breast Cancer 09/2015
1	Lymphoma (Lymphomas) 11/2012
1	Multiple Myeloma 11/2012
1	Factor VII Deficiency (Hypoproconvertinemia) 08/2012

Drug/Important Bio-Agent (IBA)

17	Hemostatics (Antihemorrhagics)IBA 10/2023 - 11/2003
13	Biomarkers (Surrogate Marker)IBA 09/2022 - 05/2010
12	Thrombin FDA Link 09/2022 - 11/2008
5	AnticoagulantsIBA 01/2023 - 10/2006
4	fibrin fragment D (D-dimer)IBA 09/2022 - 08/2017
4	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 10/2007
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2017 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2018
3	Thromboplastin (Tissue Factor)IBA 01/2023 - 07/2009
3	EnzymesIBA 01/2023 - 08/2012
3	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2020
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2011 - 01/2003
2	AntibodiesIBA 01/2021 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2021 - 12/2019
2	Conditioned Culture MediaIBA 02/2011 - 01/2008
2	Dalteparin (Dalteparin Sodium)FDA Link 01/2008 - 02/2006
1	BNT162 VaccineIBA 10/2023
1	VaccinesIBA 10/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Protein Kinases (Protein Kinase)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Inositol (Myoinositol)IBA 01/2023
1	Factor XIII (Coagulation Factor XIII)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	CollagenIBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	COVID-19 VaccinesIBA 12/2021
1	Hormones (Hormone)IBA 04/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	SolutionsIBA 01/2021
1	AntithrombinsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Prothrombin (Factor II)IBA 01/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2020
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 09/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	Purinergic P2 Receptors (ADP Receptor)IBA 07/2013
1	Adenosine Diphosphate (ADP)IBA 07/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2013
1	SteroidsIBA 11/2012
1	Immunomodulating AgentsIBA 11/2012
1	Serine Proteases (Serine Protease)IBA 08/2012
1	Factor XII (Hageman Factor)IBA 08/2012
1	CoagulantsIBA 08/2012
1	Peptide Hydrolases (Proteases)FDA Link 08/2012
1	Hydroxyurea (Hydrea)FDA LinkGeneric 09/2011
1	Vitamin K FDA Link 07/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2011
1	bemiparinIBA 02/2011
1	SelectinsIBA 07/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010
1	P-SelectinIBA 05/2010

Therapy/Procedure

9	Therapeutics 09/2022 - 08/2003
8	Drug Therapy (Chemotherapy) 09/2023 - 05/2010
1	Plasmapheresis 01/2021
1	Adjuvant Chemotherapy 01/2020
1	Remission Induction 05/2010